Medical - Care Facilities
Compare Stocks
5 / 10Stock Comparison
MNDR vs WELL vs VTR vs AMWL vs TDOC
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
REIT - Healthcare Facilities
Medical - Healthcare Information Services
Medical - Healthcare Information Services
MNDR vs WELL vs VTR vs AMWL vs TDOC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Care Facilities | REIT - Healthcare Facilities | REIT - Healthcare Facilities | Medical - Healthcare Information Services | Medical - Healthcare Information Services |
| Market Cap | $342K | $149.25B | $41.15B | $129M | $1.26B |
| Revenue (TTM) | $21M | $11.63B | $6.13B | $182M | $2.51B |
| Net Income (TTM) | $-16M | $1.43B | $260M | $-88M | $-171M |
| Gross Margin | 2.0% | 39.1% | -4.3% | 38.7% | 65.6% |
| Operating Margin | -73.8% | 4.4% | 13.4% | -50.6% | -7.6% |
| Forward P/E | — | 78.4x | 118.0x | — | — |
| Total Debt | $244K | $21.38B | $13.22B | $5M | $1.04B |
| Cash & Equiv. | $812K | $5.03B | $741M | $182M | $781M |
MNDR vs WELL vs VTR vs AMWL vs TDOC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Apr 24 | May 26 | Return |
|---|---|---|---|
| Mobile-health Netwo… (MNDR) | 100 | 0.1 | -99.9% |
| Welltower Inc. (WELL) | 100 | 223.6 | +123.6% |
| Ventas, Inc. (VTR) | 100 | 195.4 | +95.4% |
| American Well Corpo… (AMWL) | 100 | 75.9 | -24.1% |
| Teladoc Health, Inc. (TDOC) | 100 | 54.6 | -45.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MNDR vs WELL vs VTR vs AMWL vs TDOC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MNDR plays a supporting role in this comparison — it may shine differently against other peers.
WELL carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.
- 223.1% 10Y total return vs VTR's 65.0%
- Lower volatility, beta 0.13, Low D/E 49.5%, current ratio 5.34x
- Beta 0.13, yield 1.3%, current ratio 5.34x
- 35.8% FFO/revenue growth vs MNDR's -58.7%
VTR is the #2 pick in this set and the best alternative if income & stability and growth exposure is your priority.
- Dividend streak 1 yrs, beta 0.01, yield 2.1%
- Rev growth 18.5%, EPS growth 184.2%, 3Y rev CAGR 12.2%
- Beta 0.01 vs TDOC's 1.91
AMWL lags the leaders in this set but could rank higher in a more targeted comparison.
Among these 5 stocks, TDOC doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 35.8% FFO/revenue growth vs MNDR's -58.7% | |
| Value | Better valuation composite | |
| Quality / Margins | 12.3% margin vs MNDR's -73.1% | |
| Stability / Safety | Beta 0.01 vs TDOC's 1.91 | |
| Dividends | 1.3% yield, 2-year raise streak, vs VTR's 2.1%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +42.7% vs MNDR's -82.9% | |
| Efficiency (ROA) | 2.3% ROA vs MNDR's -361.4% |
MNDR vs WELL vs VTR vs AMWL vs TDOC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
MNDR vs WELL vs VTR vs AMWL vs TDOC — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
TDOC leads in 1 of 6 categories
WELL leads 1 • MNDR leads 0 • VTR leads 0 • AMWL leads 0 • 4 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — WELL and VTR each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WELL is the larger business by revenue, generating $11.6B annually — 547.5x MNDR's $21M. WELL is the more profitable business, keeping 12.3% of every revenue dollar as net income compared to MNDR's -73.1%. On growth, WELL holds the edge at +40.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $21M | $11.6B | $6.1B | $182M | $2.5B |
| EBITDAEarnings before interest/tax | -$15M | $2.8B | $2.3B | -$59M | $42M |
| Net IncomeAfter-tax profit | -$16M | $1.4B | $260M | -$88M | -$171M |
| Free Cash FlowCash after capex | -$8M | $2.5B | $1.4B | -$42M | $251M |
| Gross MarginGross profit ÷ Revenue | +2.0% | +39.1% | -4.3% | +38.7% | +65.6% |
| Operating MarginEBIT ÷ Revenue | -73.8% | +4.4% | +13.4% | -50.6% | -7.6% |
| Net MarginNet income ÷ Revenue | -73.1% | +12.3% | +4.2% | -48.2% | -6.8% |
| FCF MarginFCF ÷ Revenue | -38.4% | +21.9% | +22.4% | -22.9% | +10.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | -35.6% | +40.3% | +22.0% | -100.0% | -2.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +15.6% | +22.5% | 0.0% | +44.5% | +32.1% |
Valuation Metrics
TDOC leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 153.3x trailing earnings, WELL trades at a 4% valuation discount to VTR's 160.3x P/E. On an enterprise value basis, TDOC's 15.1x EV/EBITDA is more attractive than WELL's 66.4x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $341,509 | $149.2B | $41.1B | $129M | $1.3B |
| Enterprise ValueMkt cap + debt − cash | -$226,539 | $165.6B | $53.6B | -$48M | $1.5B |
| Trailing P/EPrice ÷ TTM EPS | -0.08x | 153.25x | 160.26x | -1.30x | -6.11x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 78.42x | 118.01x | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 66.40x | 24.31x | — | 15.13x |
| Price / SalesMarket cap ÷ Revenue | 0.06x | 13.99x | 7.05x | 0.52x | 0.50x |
| Price / BookPrice ÷ Book value/share | 0.10x | 3.35x | 3.18x | 0.50x | 0.89x |
| Price / FCFMarket cap ÷ FCF | — | 52.41x | 31.25x | — | 4.40x |
Profitability & Efficiency
Evenly matched — WELL and VTR each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
WELL delivers a 3.5% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $-6 for MNDR. AMWL carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to VTR's 1.05x. On the Piotroski fundamental quality scale (0–9), WELL scores 7/9 vs MNDR's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -6.1% | +3.5% | +2.1% | -33.5% | -12.4% |
| ROA (TTM)Return on assets | -3.6% | +2.3% | +1.0% | -25.1% | -5.9% |
| ROICReturn on invested capital | — | +0.5% | +2.5% | -95.1% | -11.5% |
| ROCEReturn on capital employed | -76.9% | +0.6% | +3.2% | -36.6% | -10.0% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 7 | 6 | 6 | 6 |
| Debt / EquityFinancial leverage | 0.12x | 0.49x | 1.05x | 0.02x | 0.75x |
| Net DebtTotal debt minus cash | -$568,048 | $16.3B | $12.5B | -$178M | $259M |
| Cash & Equiv.Liquid assets | $811,920 | $5.0B | $741M | $182M | $781M |
| Total DebtShort + long-term debt | $243,872 | $21.4B | $13.2B | $5M | $1.0B |
| Interest CoverageEBIT ÷ Interest expense | — | 0.26x | 1.40x | -239.18x | -8.76x |
Total Returns (Dividends Reinvested)
WELL leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WELL five years ago would be worth $30,234 today (with dividends reinvested), compared to $44 for MNDR. Over the past 12 months, WELL leads with a +42.7% total return vs MNDR's -82.9%. The 3-year compound annual growth rate (CAGR) favors WELL at 42.5% vs MNDR's -83.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +23.2% | +14.3% | +12.6% | +59.8% | -1.3% |
| 1-Year ReturnPast 12 months | -82.9% | +42.7% | +33.9% | +14.3% | +1.5% |
| 3-Year ReturnCumulative with dividends | -99.6% | +189.5% | +94.2% | -80.7% | -73.3% |
| 5-Year ReturnCumulative with dividends | -99.6% | +202.3% | +74.8% | -97.2% | -95.4% |
| 10-Year ReturnCumulative with dividends | -99.6% | +223.1% | +65.0% | -98.3% | -41.1% |
| CAGR (3Y)Annualised 3-year return | -83.7% | +42.5% | +24.8% | -42.2% | -35.6% |
Risk & Volatility
Evenly matched — MNDR and VTR each lead in 1 of 2 comparable metrics.
Risk & Volatility
MNDR is the less volatile stock with a -0.25 beta — it tends to amplify market swings less than TDOC's 1.91 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VTR currently trades 97.8% from its 52-week high vs MNDR's 14.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.25x | 0.13x | 0.01x | 1.47x | 1.91x |
| 52-Week HighHighest price in past year | $7.95 | $219.59 | $88.50 | $9.15 | $9.77 |
| 52-Week LowLowest price in past year | $0.66 | $142.65 | $61.76 | $3.71 | $4.40 |
| % of 52W HighCurrent price vs 52-week peak | +14.7% | +97.0% | +97.8% | +84.7% | +71.2% |
| RSI (14)Momentum oscillator 0–100 | 68.9 | 60.2 | 56.2 | 67.1 | 74.1 |
| Avg Volume (50D)Average daily shares traded | 3.1M | 2.6M | 3.4M | 59K | 5.5M |
Analyst Outlook
Evenly matched — WELL and VTR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: WELL as "Buy", VTR as "Buy", TDOC as "Hold". Consensus price targets imply 8.9% upside for TDOC (target: $8) vs 4.9% for VTR (target: $91). For income investors, VTR offers the higher dividend yield at 2.15% vs WELL's 1.30%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | — | Hold |
| Price TargetConsensus 12-month target | — | $226.50 | $90.80 | — | $7.58 |
| # AnalystsCovering analysts | — | 34 | 32 | — | 42 |
| Dividend YieldAnnual dividend ÷ price | — | +1.3% | +2.1% | — | — |
| Dividend StreakConsecutive years of raises | — | 2 | 1 | — | — |
| Dividend / ShareAnnual DPS | — | $2.76 | $1.86 | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | +0.0% | 0.0% |
TDOC leads in 1 of 6 categories (Valuation Metrics). WELL leads in 1 (Total Returns). 4 tied.
MNDR vs WELL vs VTR vs AMWL vs TDOC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is MNDR or WELL or VTR or AMWL or TDOC a better buy right now?
For growth investors, Welltower Inc.
(WELL) is the stronger pick with 35. 8% revenue growth year-over-year, versus -58. 7% for Mobile-health Network Solutions Class A Ordinary Shares (MNDR). Welltower Inc. (WELL) offers the better valuation at 153. 3x trailing P/E (78. 4x forward), making it the more compelling value choice. Analysts rate Welltower Inc. (WELL) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MNDR or WELL or VTR or AMWL or TDOC?
On trailing P/E, Welltower Inc.
(WELL) is the cheapest at 153. 3x versus Ventas, Inc. at 160. 3x. On forward P/E, Welltower Inc. is actually cheaper at 78. 4x.
03Which is the better long-term investment — MNDR or WELL or VTR or AMWL or TDOC?
Over the past 5 years, Welltower Inc.
(WELL) delivered a total return of +202. 3%, compared to -99. 6% for Mobile-health Network Solutions Class A Ordinary Shares (MNDR). Over 10 years, the gap is even starker: WELL returned +223. 1% versus MNDR's -99. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MNDR or WELL or VTR or AMWL or TDOC?
By beta (market sensitivity over 5 years), Mobile-health Network Solutions Class A Ordinary Shares (MNDR) is the lower-risk stock at -0.
25β versus Teladoc Health, Inc. 's 1. 91β — meaning TDOC is approximately -879% more volatile than MNDR relative to the S&P 500. On balance sheet safety, American Well Corporation (AMWL) carries a lower debt/equity ratio of 2% versus 105% for Ventas, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — MNDR or WELL or VTR or AMWL or TDOC?
By revenue growth (latest reported year), Welltower Inc.
(WELL) is pulling ahead at 35. 8% versus -58. 7% for Mobile-health Network Solutions Class A Ordinary Shares (MNDR). On earnings-per-share growth, the picture is similar: Ventas, Inc. grew EPS 184. 2% year-over-year, compared to -11. 5% for Welltower Inc.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MNDR or WELL or VTR or AMWL or TDOC?
Welltower Inc.
(WELL) is the more profitable company, earning 8. 8% net margin versus -44. 3% for Mobile-health Network Solutions Class A Ordinary Shares — meaning it keeps 8. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VTR leads at 14. 2% versus -46. 4% for MNDR. At the gross margin level — before operating expenses — TDOC leads at 69. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MNDR or WELL or VTR or AMWL or TDOC more undervalued right now?
On forward earnings alone, Welltower Inc.
(WELL) trades at 78. 4x forward P/E versus 118. 0x for Ventas, Inc. — 39. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TDOC: 8. 9% to $7. 58.
08Which pays a better dividend — MNDR or WELL or VTR or AMWL or TDOC?
In this comparison, VTR (2.
1% yield), WELL (1. 3% yield) pay a dividend. MNDR, AMWL, TDOC do not pay a meaningful dividend and should not be held primarily for income.
09Is MNDR or WELL or VTR or AMWL or TDOC better for a retirement portfolio?
For long-horizon retirement investors, Ventas, Inc.
(VTR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 01), 2. 1% yield). Teladoc Health, Inc. (TDOC) carries a higher beta of 1. 91 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (VTR: +65. 0%, TDOC: -41. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MNDR and WELL and VTR and AMWL and TDOC?
These companies operate in different sectors (MNDR (Healthcare) and WELL (Real Estate) and VTR (Real Estate) and AMWL (Healthcare) and TDOC (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: MNDR is a small-cap quality compounder stock; WELL is a mid-cap high-growth stock; VTR is a mid-cap high-growth stock; AMWL is a small-cap quality compounder stock; TDOC is a small-cap quality compounder stock. WELL, VTR pay a dividend while MNDR, AMWL, TDOC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.